Relmada Therapeutics Inc (RLMD)’s financial ratios: A comprehensive overview

In the latest session, Relmada Therapeutics Inc (NASDAQ: RLMD) closed at $4.65 up 1.31% from its previous closing price of $4.59. In other words, the price has increased by $+0.0600 from its previous closing price. On the day, 113400 shares were traded.

Ratios:

For a deeper understanding of Relmada Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.00 and its Current Ratio is at 8.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on October 14, 2022, Downgraded its rating to Hold and sets its target price to $10 from $90 previously.

Goldman Downgraded its Buy to Neutral on October 14, 2022, whereas the target price for the stock was revised from $81 to $8.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 31 ’24 when TRAVERSA SERGIO bought 27,460 shares for $4.00 per share. The transaction valued at 109,752 led to the insider holds 244,024 shares of the business.

Ence Chuck bought 13,670 shares of RLMD for $55,429 on Jan 31 ’24. The CA and CO now owns 38,970 shares after completing the transaction at $4.05 per share. On Jan 31 ’24, another insider, Shenouda Maged, who serves as the Chief Financial Officer of the company, bought 6,875 shares for $4.06 each. As a result, the insider paid 27,943 and bolstered with 34,903 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 138.50M and an Enterprise Value of 42.18M.

Stock Price History:

Over the past 52 weeks, RLMD has reached a high of $7.22, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is 5.0802, while the 200-Day Moving Average is calculated to be 3.4943.

Shares Statistics:

For the past three months, RLMD has traded an average of 294.78K shares per day and 284.55k over the past ten days. A total of 30.10M shares are outstanding, with a floating share count of 25.38M. Insiders hold about 15.90% of the company’s shares, while institutions hold 52.40% stake in the company. Shares short for RLMD as of Mar 15, 2024 were 1.75M with a Short Ratio of 5.94, compared to 1.73M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.81% and a Short% of Float of 5.90%.

Earnings Estimates

There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.85 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$0.92, while EPS last year was -$0.87. The consensus estimate for the next quarter is -$0.88, with high estimates of -$0.75 and low estimates of -$1.

Analysts are recommending an EPS of between -$2.61 and -$3.8 for the fiscal current year, implying an average EPS of -$3.06. EPS for the following year is -$2.36, with 5 analysts recommending between -$1.6 and -$4.12.

Most Popular